Pancreatic cancer surgery patients have a life expectancy of about 2 to 3 years after resection in the middle stage. Pancreatic cancer usually does not have any clinical manifestations in the early stage, and when the patient develops symptoms, such as abdominal distension, abdominal pain and jaundice, the disease has usually progressed to the middle or late stage, and the optimal period of cure is lost. For intermediate pancreatic cancer patients, surgical treatment needs to be followed by radiation therapy and chemotherapy. However, the five-year survival rate for this disease is usually around 50 percent. Therefore, after surgery, patients are usually able to continue to live for about two to three years. Patients can consult with the hepatobiliary and pancreatic surgery department of their local hospitals and listen to the advice of specialized doctors to choose a reasonable way of treatment.